Gene · 3669
Papers4,236
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 4,236
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The interplay between N6-methyladenosine and precancerous liver disease: molecular functions and mechanisms. | Discov Oncol | 2023 | 37227534 | PubTator, text mining | PubMed |
Randomized, Phase II study of pemetrexed plus bevacizumab versus pemetrexed alone after treatment with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous, non-small cell lung cancer: TORG (thoracic oncology research group) 1321. | Cancer Med | 2023 | 37226421 | PubTator, text mining | PubMed |
| Antigen Recognition and Immune Response to Acute and Chronic Hepatitis B Virus Infection. | J Inflamm Res | 2023 | 37223107 | PubTator, text mining | PubMed |
| Assessing SARS-CoV-2-specific T-cell reactivity in late convalescents and vaccinees: Comparison and combination of QuantiFERON and activation-induced marker assays, and relation with antibody status. | PLoS One | 2023 | 37220145 | PubTator, text mining | PubMed |
| Deep Proteomics Network and Machine Learning Analysis of Human Cerebrospinal Fluid in Japanese Encephalitis Virus Infection. | J Proteome Res | 2023 | 37219084 | PubTator, text mining | PubMed |
| Skin infiltrating T-cell profile of drug reaction with eosinophilia and systemic symptoms (DRESS) reactions among HIV-infected patients. | Front Med (Lausanne) | 2023 | 37215719 | PubTator, text mining | PubMed |
| How to improve the outcomes of elderly acute myeloid leukemia patients through allogeneic hematopoietic stem cell transplantation. | Front Immunol | 2023 | 37207218 | PubTator, text mining | PubMed |
| Hairy cell leukemia with isolated bone lesions. | Clin Case Rep | 2023 | 37207087 | PubTator, text mining | PubMed |
| HIV infection and cardiovascular disease have both shared and distinct monocyte gene expression features: Women's Interagency HIV study. | PLoS One | 2023 | 37205656 | PubTator, text mining | PubMed |
| Compromised T-cell immunity in patients with spinal cord injury and its relationship with injury characteristics. | Turk J Phys Med Rehabil | 2023 | 37201015 | PubTator, text mining | PubMed |
| Association between HSP-Specific T-Cell Counts and Retinal Nerve Fiber Layer Thickness in Patients with Primary Open-Angle Glaucoma. | Ophthalmol Sci | 2023 | 37197701 | PubTator, text mining | PubMed |
| Precancerous Lesions of the Head and Neck Region and Their Stromal Aberrations: Piecemeal Data. | Cancers (Basel) | 2023 | 37190121 | PubTator, text mining | PubMed |
| Invasive Cutaneous Candidiasis, Autoimmune Hemolytic Anemia and Pancytopenia: A Challenging Scenario for Waldenström Macroglobulinemia in an Elderly Patient. | Biomedicines | 2023 | 37189625 | PubTator, text mining | PubMed |
| Circulating Regulatory T Cell Subsets in Patients with Sarcoidosis. | Diagnostics (Basel) | 2023 | 37189479 | PubTator, text mining | PubMed |
| Transient and tunable CRISPRa regulation of APOBEC/AID genes for targeting hepatitis B virus. | Mol Ther Nucleic Acids | 2023 | 37187708 | PubTator, text mining | PubMed |
| The Influence of Antibodies against Angiotensin II Type-1 Receptor on the Outcome of Kidney Transplantation: A Single-Center Retrospective Study. | J Clin Med | 2023 | 37176553 | PubTator, text mining | PubMed |
| Immunophenotypic Alterations in Adult Patients with Steroid-Dependent and Frequently Relapsing Nephrotic Syndrome. | Int J Mol Sci | 2023 | 37175393 | PubTator, text mining | PubMed |
| ATM Inhibition-Induced ISG15/IFI27/OASL Is Correlated with Immunotherapy Response and Inflamed Immunophenotype. | Cells | 2023 | 37174688 | PubTator, text mining | PubMed |
| A web-based integrative transcriptome analysis, RNAseqChef, uncovers the cell/tissue type-dependent action of sulforaphane. | J Biol Chem | 2023 | 37172729 | PubTator, text mining | PubMed |
| Accelerated waning of the humoral response to COVID-19 vaccines in obesity. | Nat Med | 2023 | 37169862 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3669/papers?page=27